Tobacco Firms Get Say on Exemption Proof Paperwork Burdens
Published Date: 6/27/2025
Notice
Summary
The FDA wants your thoughts on a plan about which tobacco products don’t need to prove they’re similar to existing ones before being sold. This affects tobacco companies and could speed up how some products reach the market. You’ve got 60 days to share your ideas, and this could save time and paperwork for businesses.
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
Proposed Exemptions for Tobacco Firms
The FDA is asking for public comment on proposed exemptions from substantial equivalence requirements for tobacco products. This proposal could let some tobacco products reach the market faster and may save time and paperwork for tobacco companies. The Agency is accepting comments for 60 days under the Paperwork Reduction Act.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16296, Substances Generally Recognized as Safe
The Food and Drug Administration (FDA or we) is proposing to require the submission of generally recognized as safe (GRAS) notices for the use of a human or animal food substance purported to be GRAS under the conditions of its intended use under the Federal Food, Drug, and Cosmetic Act (FD&C Act).
2026-14073, Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign Establishments
The FDA wants to make it easier for drug makers who work in several locations to register as one company instead of many. They’re also updating rules for foreign drug companies to match new laws about handling health threats. If you’re in drug manufacturing, get ready to comment by September 11, 2026, and keep an eye on possible paperwork changes that could affect your business.
2026-13047, Establishment Registration and Product Listing for Tobacco Products
The FDA wants to make sure all tobacco product makers, both in the U.S. and abroad, register their businesses and list their products. This new rule closes a big gap by including foreign companies, helping the FDA keep better track of tobacco products for public health. Comments on this proposal are open until September 14, 2026, so affected businesses should get ready to update their info and possibly face new costs.
2026-16959, Frequently Asked Questions-Developing Potential Cellular and Gene Therapy Products; Final Guidance for Industry; Availability
The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance titled "Frequently asked Questions--Developing Potential Cellular and Gene Therapy Products." The guidance document provides industry with answers to frequently asked questions (FAQs) and commonly faced issues that arise during the development of cellular and gene therapy (CGT) products. The FAQs represent common questions directed to the Agency and span multiple disciplines, including regulatory review; chemistry, manufacturing, and controls (CMC); pharmacology/toxicology; clinical; and clinical pharmacology. This guidance announced in this notice finalizes the draft guidance of the same title issued on November 19, 2024.
2026-16942, Food Additives Permitted in Feed and Drinking Water of Animals; Chromium DL-methionine Chelate
The Food and Drug Administration (FDA, we, or the Agency) is amending the regulations for food additives permitted in feed and drinking water of animals to provide for the safe use of chromium DL- methionine chelate as a nutritional source of chromium in cattle feed. This action is in response to a food additive petition filed by Zinpro Corp.
2026-16939, GNT USA, LLC.; Filing of Color Additive Petition
The Food and Drug Administration (FDA or we) is announcing that we have filed a petition, submitted by GNT USA, LLC., c/o Exponent, Inc., proposing that we amend our color additive regulations to provide for the safe use of safflower (Carthamus tinctorius L.) extract as a color additive in various foods at levels consistent with good manufacturing practices.
Previous / Next Documents
Previous: 2025-11949, Agency Information Collection Activities; Proposed Collection; Comment Request; Production, Storage, and Transportation of Shell Eggs (Preventing Salmonella Enteritidis)
The FDA wants to hear from shell egg producers about their recordkeeping and registration rules to help prevent Salmonella infections. They’re asking for feedback on how collecting this info works and if it can be improved. This is a chance to shape rules that keep eggs safe without causing extra hassle or costs.
Next: 2025-11951, Agency Information Collection Activities; Proposed Collection; Comment Request; Registration of Food Facilities
The FDA wants your thoughts on updating the rules for food facility registration, which affects anyone who makes, processes, packs, or stores food in or for the U.S. They’re asking for comments over the next 60 days to keep things clear and efficient, with no new fees involved. This helps keep our food safe and the paperwork smooth for businesses big and small.